Cellectis (CLLS) Reports Q2 Loss of EUR0.23/Share
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.23), versus (EUR0.43) reported last year. Revenue for the quarter came in at EUR18.14 million, versus EUR8 million reported last year.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
